Parthenon Ther­a­peu­tics CEO ex­its weeks af­ter co-founder leaves

Parthenon Ther­a­peu­tics’ CEO and co-founder Lau­rent Au­doly is no longer steer­ing the ship of the can­cer biotech, End­points News has learned.

Au­doly’s de­par­ture comes just weeks af­ter co-founder and chief busi­ness and op­er­at­ing of­fi­cer Ol­ga Granatur­o­va left to take on the same posts at Nor­mu­ni­ty, an­oth­er pri­vate­ly-held im­munother­a­py start­up. CSO Tamas Oravecz al­so trad­ed in his CSO hat for the same role at Sim­cere last Au­gust.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER